Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion
Sponsors
Norges Idrettshoegskole, Institut De Cancerologie De L Ouest, Leids Universitair Medisch Centrum (LUMC), Oslo University Hospital HF, Region Sjaelland
Conditions
Anabolic resistanceAnti-DopingBrain metastases of cancer > brain radionecrosisCentral retinal artery occlusionColon cancerFibrous dysplasia/McCune-Albright syndromeHealthy agingSarcopenia
Phase 2
Does human skeletal muscle possess an epigenetic memory of testosterone
Active, not recruitingCTIS2023-507815-37-00
Start: 2024-08-01Target: 40Updated: 2025-08-14
Effect of low-dose Interferon-alfa2a on perioperative immune suppression
RecruitingCTIS2024-517619-65-00
Start: 2023-08-28Target: 68Updated: 2026-01-20
Phase 3
DEnosumab for the treatment of FIbrous Dysplasia/McCune-Albright Syndrome in adults (DeFiD): a randomized double-blind placebo-controlled trial
RecruitingCTIS2024-511090-30-00
Start: 2023-06-13Target: 82Updated: 2025-01-27
Corticodependent or corticoresistant brain radionecrosis after radiotherapy for brain metastases: a multicentre randomized, controlled double-blind phase III study, comparing bevacizumab versus placebo (BRADI)
RecruitingCTIS2024-510893-25-00
Start: 2025-04-29Target: 84Updated: 2025-09-23
A double-blind randomized placebo-controlled four-arm trial to assess the efficacy of oral bicarbonate and intravenous butylscopolamine bromide to facilitate spontaneous (non-operative) delivery in pregnant female participants with induction of labor.
Active, not recruitingCTIS2024-511848-55-00
Start: 2023-01-03Target: 3000Updated: 2024-10-09
TENECTEPLASE IN CENTRAL RETINAL ARTERY OCCLUSION STUDY
(TenCRAOS):
A Prospective, randomised-controlled, double-dummy, double-blind phase 3 multi-centre trial of
TNK 0.25 mg/kg + placebo vs. ASA + placebo (2 arms with 1:1 block randomisation)
RecruitingCTIS2024-517606-29-00
Start: 2020-10-30Target: 76Updated: 2024-11-05